AbbVie Inc. (TSX:ABBV)
40.28
+0.28 (0.70%)
Nov 6, 2026, 4:00 PM EST
AbbVie Employees
AbbVie had 57,000 employees as of December 31, 2025. The number of employees increased by 2,000 or 3.64% compared to the previous year.
Employees
57,000
Change (1Y)
2,000
Growth (1Y)
3.64%
Revenue / Employee
1.64M CAD
Profits / Employee
256.61K CAD
Market Cap
725.92B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 57,000 | 2,000 | 3.64% |
| Dec 31, 2024 | 55,000 | 5,000 | 10.00% |
| Dec 31, 2023 | 50,000 | 0 | - |
| Dec 31, 2022 | 50,000 | 0 | - |
| Dec 31, 2021 | 50,000 | 3,000 | 6.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,500 |
| Sienna Senior Living | 15,000 |
| Apotex Health | 6,000 |
| Curaleaf Holdings | 5,554 |
| Green Thumb Industries | 4,900 |
| Verano Holdings | 3,800 |
| WELL Health Technologies | 1,507 |
| Knight Therapeutics | 830 |
AbbVie News
- 1 day ago - Healthcare Stocks Fall as Market Rout Spreads - WSJ
- 3 days ago - AbbVie price target raised to $315 from $285 at Freedom Broker - TheFly
- 3 days ago - AbbVie expands Oxford R&D facility as part of £120 million-plus investment - Reuters
- 4 days ago - Allergan Aesthetics to Present New Research on Aesthetic Care Following Medical Weight Loss and Evolving Patient Needs at ASDS 2026 - PRNewsWire
- 5 days ago - AbbVie price target raised to $330 from $280 at RBC Capital - TheFly
- 5 days ago - AbbVie price target raised to $325 from $279 at Leerink - TheFly
- 5 days ago - AbbVie price target raised to $325 from $279 at Leerink - TheFly
- 5 days ago - AbbVie signs global license agreement with Brise Pharmaceuticals in migraine - TheFly